VAN ZANDT, MICHAEL,GOLEBIOWSKI, ADAM,JI, MIN KOO,WHITEHOUSE, DARREN,RYDER, TODD,BECKETT, PAUL
申请号:
MYPI 2012004640
公开号:
MY162535A
申请日:
2011.04.20
申请国别(地区):
MY
年份:
2017
代理人:
摘要:
Compounds according to Formula I and Formula II are potent inhibitors of Arginase I and II activity: where R1,R2, R3,R4,R5,R6,R7,R8,R9, D,M,X, and Y are defined as set forth in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use for treating or preventing a disease r a condition associated with arginase activity.